EPO and EAPO launch new PPH agreement

In Insights

10 August, 2017

The ever-expanding PPH (Patent Prosecution Highway) network keeps getting new additions. As always, AWA Point sums up the latest expansions and arising possibilities. 

To recall, for a given PPH agreement, the PPH allows for requesting accelerated examination at the one office participating in this agreement based on the search results and a set of claims accepted for grant in an analogous application at the other participating office.

Most recently, the PPH agreements between the EPO (European Patent Office) and the Malaysian and Philippine patent offices, respectively, have entered into force. The agreements apply to both national and PCT work products.

Furthermore, The EPO and the Eurasian Patent Office, EAPO, have announced the signing of a PPH agreement to enter into force later this year.

In addition, the patent offices of New Zealand and Colombia have both joined the Global PPH agreement as of 6 July 2017. Thereby, effective PPH agreements exist between the patent offices of New Zealand and Colombia, respectively, and, i.e., the Danish and Swedish patent offices as well as Nordic Patent Office.

Finally, it is worth mentioning that the Turkish IP office has also joined the PPH network. Namely, the Turkish IP office has signed an agreement with the Spanish patent office, OEPM.

An overview of existing and working agreements under the Global PPH at the time of writing can be seen on the PPH website compiled by the Japanese Patent Office, JPO. Please click here.

You may also be interested in:

German decision on UPC expected in early 2020

In an interview with IP industry publication Managing IP, Justice Huber of the German Federal Constitutional Court stated that

Read more...

AMS Neve vs. Heritage Audio: What does the CJEU ruling mean for online infringement cases?

EU-trademark owners receive much needed clarity on jurisdiction in online infringement cases The internet’s boundless nature provides EU-trademark owners

Read more...

The Crispr-Cas9 patent tussle continues: The case of UC Berkeley at the EPO

In Europe, we don’t do things the way the Americans do… Oral proceedings in the opposition against UC Berkeley’s

Read more...

Mobile Sliding Menu